|
|
For Clinicians
Publications:
Publications may be obtained at university libraries, or through the internet on: www.pubmed.gov. For more information regarding publications, please call the Hemophilia Treatment Center at (213) 742-1403.
Kasper CK, Buzin CH. Genetics of Hemophilia A and B (book). Southland Publications, Pasadena, CA, 2008.
Kasper CK, Lin JC. Prevalence of familial versus sporadic hemophilia. Haemophilia 2007; 13:90-92.
Kasper CK. Products for clotting factor replacement in developing countries. Semin Thromb Hemost 2005; 31:507-512,
Silva M and Luck JV Jr: Long term results of primary total knee replacement in hemophilia. J Bone Joint Surgery-AM, 87(A) 85-91, 2005.
Silva M and Luck JV Jr: Results of radial head excision in hemophilic patients. Proceedings of the 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons, Washington D.C., p. 528, 2005.
Kasper CK. AIDS, hepatitis and hemophilia. J Thromb Haemost. 2004; 2:516-8
Saab S, Cho D, Quon DV, Ibrahim AB, Dong P, Marder VJ and Logan LJ: Same day outpatient transjugular liver biopsies in haemophilia. Haemophilia. 10:727-731, 2004.
Silva M, Luck JV Jr and Llinas A: Chronic Haemophilic Synovitis: The role of Radiosynovectomy. Treatmetn of Hemophilia Monograph Series No. 33, World Federation of Hemophilia, 2004.
Luck JV Jr, Silva M, Rodriguez-Merchan C, Ghalambor N, Zahiri CA and Finn RS: Hemophilic Arthropathy. J Am Acad Orthop Surg, 12:234-245, 2004.
Silva M and Luck JV Jr: Results of radial head excision in hemophilic patients. Abstracts of the XXV International Congress of The World Federation of Hemophilia, Bangkok, Thailand. Haemophilia, 10 (Suppl 3), p. 83, 2004.
Silva J and Luck JV Jr: Flexion Contracture of the Knee in Hemophilia. In: Rodriguez-Merchan, C., (ed) The Haemophilic Joints: New Perspectives. First edition, Blackwell, Oxford, p. 99-, 2003.
Rodriguez-Merchan EC, Luck JV Jr, Silva M and Quintana M: Synoviorthesis in haemophilia. In: Rodriguez-Merchan, C., (ed) The Haemophilic Joints: New Perspectives. First edition, Blackwell, Oxford, p. 73-, 2003.
Rodriquez-merchan EC, Luck JV Jr, Silva M, Riera JA, Wiedel JD, Goddard NJ, Heim M and Soliemeno PL: Total knee replacement in the haemophilic patient. In: Rodriguez-Merchan, C., (ed) The Haemophilic Joints: New Perspectives, First edition, Blackwell, Oxford, p. 116-, 2003.
Lee H, Marder VJ, Logan LJ, Friedman S and Miller BJ: Fulminant thrombotic thrombocytopenic purpura (TTP) in a patient with sickle cell-hemoglobin C disease. Ann Hermatol 82:702-704, 2003.
Manco-Johnson MJ, Riske B, Kasper CK. Advances in care of children with hemophilia. Semin Thromb. Hemost 2003; 29:585-94.
Silva M and Luck JV Jr: Long-term Results of Primary Total Knee Replacement in Hemophilia. Proceedings of the 70th Annual Meeting, American Academy of Orthopaedic Surgeons, New Orleans, LA, p. 147, 2003.
Logan LJ: “Hemophilia,” Medical Psychosocial and Vocational Aspects of Disability, (ed) Martin G. Brodwin, Fernando Telez and Sandra K. Broadwin (Elliott & Fitzpatrick, Second edition, 2002) Chapter 15, pp. 185-198.
Luck JV Jr and Silva M: Results of Primary Total Knee Replacement in Hemophilia. XXV International Congress of the World Federation of Haemophilia. Seville, Spain, May 2002.
Silva M, Luck JV Jr and Siegel ME: Radiosynovectomy for Chronic Hemophilic Synovitis. Haemophilia, 7 Suppl (2) 40-49, 2001.
Luck, JV Jr: “Orthopaedic Management of Hemophilic Arthropathy,” in Chapman’s Orthopaedic Surgery, Third edition, (ed) Michael W. Chapman, Philadelphia, PA, 2001, Lippencott-Williams & Wilkins.
Luck JV Jr, Lin JC, Kasper CK and Logan LJ: “Operative Orthopaedics” (Lippincott, Williams, Third edition, 2001), Chapter 136.
Luck JV Jr, Lin JC, Kasper CK, Logan LJ. Orthopaedic Management of Hemophilic Arthropathy. In Chapman’s Orthopaedic Surgery, ed. By Michael CW. Chapman; Lippincott Williams & Wilkins, Philadelphia, 2001
Logan LJ: “Hemophilia,” Medical, Psychosocial and Vocational Aspects of Disability, (ed) Martin G. Broadwin (Elliot & Fitzpatrick, 2001) Chapter 17.
O’Gorman P, DiMichele DM, Kasper CK, Mannucci PM, Santagostini E, Hay CRM. Continuous infusion of porcine factor VIII in patients with haemophilia a and high-responding inhibitors: stability and clinical experience. Haemophilia 7:537-543, 2001
Kasper CK. Protocols for the treatment of haemophilia and von Willebrand Disease. Haemophilia 2000; 6: (suppl 1); 84-93
Silva M, Luck JV Jr, Siegel ME and Siegel HJ: Clinical Utilization of P32 Chronic Phosphate Radiosynovectomy in Haemophilia: Analysis of Efficacy, Safety and Cost. Haemophilia, 6;4:398, 2000.
Hay CR, Ludlam CA, Colvin BT, Hill FG, Preston FE, Waseem N, Bagnall R, Peake IR, Berntorp E, Mauser-Bunschoten EP, Fijnvandraat K, Kasper CK, White GC, Santagostino E. Factor VIII inhibitors in mild and moderate-severity haemophilia A. Thrombosis and Haemostasis 79:762-66, 1998.
Siegel ME, Siegel HJ and Luck JV Jr: Radiosynovectomy’s Clinical Applications and Cost Effectiveness: A Review. Semin Nucl Med, Oct;27(4):364-371, 1997.
Hay CRM, Lozier JN, Lee CA, Laffan M, Tradati F, Santagostino E, Ciavarella N, Schiavoni M. Fukui H, Yoshioka A, Teitel J, Mannucci PM, Kasper CK. Safety Profile of Porcine Factor VIII and Its Use as Hospital and Home-Therapy for Patients with Haemophilia-A and Inhibitors: the Results of An International Survey. Thrombosis and Haemostasis 75:25-29, 1996.
Luck JV Jr, Logan LJ, Benson DR and Glasser DB: Human Immunodeficiency Virus Infection: Complications and Outcomes of Orthopaedic Surgery, Journal of American Academy of Orthopedic Surgery, 466:297-304, 1996.
Kasper CK. In Vivo Recovery and Early Half-Life of Infused Factor VIII in Hemophilia A. Haemophilia, Vol. 1, Issue #1, 14-16, 1995.
Logan LJ: Hemostasis: Hemorrhagic and Thrombotic Disorders, Manual of Hematology, (ed) Joseph J. Mazza (Little, Brown, Second edition, 1995), pp. 349-379.
Siegel HJ, Luck JV Jr, Siegel ME, Quines C and Anderson E: P-32 Chronic Phosphate Radiosynovectomy for the Treatment of Hemarthrosis and Synovitis Associated with Hemophilia: Clinical Utility. Radiology, 190:1, 257-261, 1994.
Luck JV Jr.: Orthopaedic Surgery on the HIV-Positive Patient: Complications and Outcomes. Instructional Course Lectures (AAOS), 43:543-549, 1994.
Mariani G, Scheibel E, Nogao T, Kasper CK, Ewing NP, Mauser-Bunschoten E, Ghirardini A, Bellocco R, and Brackman HH, for the paraticipants in the International Registry of Immunetolerance Protocols. Immunetolerance as Treatment of Alloantibodies to Factor VIII in Hemophilia. Semin Hematol, 31, Suppl 4:62-64, 1994.
Lozier JN, Santagostino E, Kasper CK, Teitel JM, Hay CRM. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors. Semin Hematol 30:10-21, 1993.
Addiego J, Kasper CK, Hilgartner M, Lusher JM, Glader B, Aledort L. Frequency of inhibitor development in haemophiliacs treated with low-purity Factor VIII. The Lancet 342:462-464, 1993.
Luck JV Jr: “Surgical Management of Hemophilic Arthropathy,” in Operative Orthopaedics – Second edition, Philadelphia, PA, 1993, 4:3441-3447, Lippencott-Raven.
Logan LJ: “Treatment of von Willibrand’s Disease,” Hematology/Oncology Clinics of North America, (ed) John Penner and H Houssana (W.B. Saunders Co., 1992 Oct), pp. 1079-1094.
Luck JV Jr and Kasper CK: “Hemophilic Arthropathy,” in Orthopaedic Rehabilitation – Second edition, 1992, 583-599.
Luck JV Jr: Surgical Management of Advanced Hemophilic Anthropathy. Prog Clin Ciol Res, 324:241-256, 1990.
Logan LJ: Rev. of “Management of von Willebrand’s Disease,” Prog Clinical Biological Research, 324:279-90, 1990.
Schwartz RS, Abildgaard CF, Aledort LM, Arkin S, Bloom AL, Brackmann HH, Brettler DB, Fukui H, Hilgartner MW, Inwood MJ, Kasper CK, Kernoff PBA, Levine PH, Lusher JM, Mannucci PM, Scharrer I, MacKenzie MA, Pancham N, Kuo HS, Allred, RU and the Recombinant Factor VIII Study Group. Human recombinant DNA-Derived antihemophilic factor (Factor VIII) in the treatment of hemophilia A. New England Journal of Medicine. 323:1800-1805,1990.
Luck JV Jr and Kasper CK: Surgical Management of Advanced Hemophilic Arthropathy. An Overview of Twenty Years’ Experience. Clin Orthop, 242:60-82, 1989.
Rousell RH, Kasper CK, Schwartz RS: The pharmacology of a new pasteurized antihemophilic factor concentrates derived from human blood plasma. Transfusion 29:208-212, 1989.
Ewing NP, Sanders NL, Dietrich SL, Kasper CK: Induction of immune tolerance to factor VIII in hemophiliacs with inhibitors. Journal of the American Medical Association, 259:65-68, 1988.
Logan LJ: “Pre- and post-operative aspects of endoprosthesis in hemophiliacs.” IIIrd van Creveld Symposium, pp. 37-43, 1988 Apr.
Graham JB, Rizza Cr, Chediak J, Mannucci PM, Briet E, Ljung R, Kasper CK, Essien EM, Green PP: Carrier detection in hemophilia A: A cooperative international study. I. The carrier phenotype. Blood, 67: 1554-1559, 1986.
Green PP, Mannucci PM, Briet E, Ljung R, Kasper CK, Essien EM, Chediak J, Rizza CR, Graham JB: Carrier detection in hemophilia A: A cooperative international study. II. The efficacy of linear discriminants. Blood, 67: 1560-1567, 1986.
Fay PJ, Cavallaro C, Marder VJ, Pancham N, Fournel MA and Schroeder DD: Comparison of the invivo survival of human factor VIII with and without von Willebrand factor in the hemophilic dog. Thromb Res 41:425-429, 1986.
Kasper CK, Ewing NP: Acquired inhibitors of plasma coagulation factors. Journal of Medical Technology, 3:431-439, 1986.
Kasper CK, Dietrich SL. Comprehensive Management of Haemophilia. Clinics in Haematology, 14(2):489-512, June 1985.
Kasper CK, Boylen AL, Ewing NP, Luck JV Jr and Dietrich SL: Hematologic Management of Hemaphilia A for Surgery. JAMA, March 253(9), 1279-1283, 1985.
Luck JV Jr: editor, International Symposia on Orthopaedic Surgery in Hemophiliacs, 1979, 1983 - a collection of 31 articles based on two symposia held at Orthopaedic Hospital, Berkeley, CA, 1985, P.F.M.
Luck JV Jr: “Prosthetic Arthroplasty of the Knee in Hemophiliacs,” in International Symposia on Orthopaedic Surgery in Hemophiliacs, 1979, 1983, Berkeley, CA 1985, P.F.M.
Luck JV Jr: “Hemophilic Pseudotumors,” in International Symposia on Orthopaedic Surgery in Hemophiliacs, 1979, 1983, Berkeley, CA, 1985.
Kasper CK, Boylen AL, Dietrich SL, Ewing NP, Luck JV Jr: Hematologic management of hemophilia A for surgery. Journal of the American Medical Association, 253: 1279-1283, 1985.
Kreiss JK, Kitchen LW, Prince HE, Kasper CK, Essex M: Antibody to human T-lymphocyte virus type III in wives of hemophiliacs: Evidence for heterosexual transmission. Annals of Internal Medicine, 102: 623-626, 1985.
De La Fuente B, Kasper CK, Rickles FR, Hoyer LW: The response of patients with mild and moderate hemophilia A and von Willebrand’s disease to treatment with desmopressin (DDAVP). Annals of Internal Medicine, 103: 6-14, 1985.
Francis RB Jr, Kasper CK: Reproduction in hemophilia. Journal of the American Medical Association, 250:3192-95, 1983.
Ewing NP, Kasper CK: In vitro detection of mild inhibitors to factor VIII in hemophilia. American Journal of Clinical Pathology, 77: 749-752, 1982.
Luck JV Jr: “Knee Surgery in Hemophilia,” in Hemophilia in the Child and Adult, (ed) Margaret Hilgartner, 1982.
Luck JV Jr: “Prosthetic Knee Arthroplasty for Advanced Hemophilic Arthroplasty, Preliminary Report,” in Hemophilia, (ed) Uri Seligsohn; 1981, Castle Publication.
Luck JV Jr: “Prosthetic Arthroplasty of the Knee for Advanced Hemophilic Arthropathy” in Orthopaedic Treatment of Musculoskeletal Lesions in Hemophilia, (ed) F. Fernandez-Palazzi, Stuttgart, 1981, F.K. Schattaur Verlag.
Luck JV Jr: “Prosthetic Knee Arthroplasty in the Hemophiliac,” in Orthopaedic Management of Hemophilia, (ed) Marvin Gilbert; 1980, Cutter Publications.
Luck JV Jr: “Knee Surgery in Hemophiliacs,” Orthopaedic Hospital Alumni Scientific Meeting, Los Angeles, 1977.
Kasper CK: Hematologic care. in Comprehensive Management of Hemophilia ed by DC Boone. FA Davis Co., Philadelphia, 1976, pp 3-17.
Kasper CK: Self-infusion. in Handbook of Hemophilia ed by KM Brinkhous and HC Hemker. Excerpta Medica, Amsterdam, 1975 pp 597-602.
Kasper CK, Parton L: Reproduction in hemophilia. Western Journal of Medicine, 120: 273-277, 1974.
Kasper CK: Incidence and course of inhibitors among patients with classic hemophilia. Thrombosis et Diathesis Haemorrhagica, 30: 263-271, 1973.
Kasper CK, Rapaport SI: Bleeding times and platelet aggregation after analgesics in hemophilia. Annals of Internal Medicine, 77: 189-193, 1972.
Kasper CK, Dietrich SL, Rapaport SI: Hemophilia prophylaxis with factor VIII concentrate. Archives of Internal Medicine, 125: 1004-1009, 1970.
Kasper CK: Surgical operation in hemophilia B: Use of factor IX concentrate. California Medicine 113: 4-8, 1970.
Feinstein D, Chong MNY, Kasper CK, Rapaport SI: Hemophilia A: Polymorphism detectable by a factor VIII antibody. Science 163: 1701-1702, 1969.
Kasper CK, Whissell DYE, Aggeler PM: Hageman factor (Factor XII) in an affected kindred and in normal adults. British Journal of Haematology, 14:543-551, 1968.
Shulman NR, Cowan DH, Libre EP, Watkins SE Jr and Marder VJ: The physiological basis for therapy of classical hemophilia (factor VIII deficiency) and related disorders. Combined Clinical Staff Conference, NIH, Ann Int Med 7:856-882, 1967.
Marder VJ and Shulman NR: Major surgery in classical hemophilia using Fraction I. Experience in twelve operations and review of the literature. Amer J Med 41:56-75, 1966.
Marder VJ, Gamble JW and Shulman NR: The use of fraction I for oral surgical procedures in patients with classic hemophilia. Report of seven cases. J Oral Surg 24:487-499, 1966.
Kasper CK, Hoag MS, Aggeler PM, Stone S: Blood clotting factors in pregnancy: Factor VIII concentrations in normal and AHF-deficient women. Obstetrics and Gynecology, 24: 242-247, 1964.
Marder VJ and Shulman NR: Clinical aspects of congenital factor VII deficiency. Amer J Med 37:182-194, 1964.
Shulman NR, Marder VJ and Hiller MC: A new method for measuring minimum invivo concentrations of factor VIII applied in distribution and survival studies and in detecting factor VIII inhibitors. In The Hemophilias, Brinkhous KM (ed), Chapel Hill, University of North Carolina Press, 1964, p. 29-43.
To Top / Menu
|
